The literature provides abundant evidence that mesenchymal stem cells (MSCs) are an
attractive resource for therapeutics and have beneficial effects in regenerating injured …

In the absence of repair mechanisms involving angiogenesis and cardiomyogenesis, loss of
cardiomyocytes after myocardial injury is a primary causative factor in the progression …

Hypoxia‐mimetic agents are new potential tools in MSC priming instead of hypoxia
incubators or chambers. Several pharmaceutical/chemical hypoxia‐mimetic agents can be …

Endothelial dysfunction induced by unordered metabolism results in vascular reconstruction
challenges in diabetic lower limb ischemia (DLLI). Mesenchymal stem cells (MSCs) are …

Cell-based therapy (CBT) is a revolutionary approach for curing a variety of degenerative
diseases. Stem cell-based regenerative medicine is a novel strategy for treating tissue …

Transplantation using stem cells including bone marrow mesenchymal stem cells (BMSCs)
is emerging as a potential regenerative therapy after ischemic attacks in the heart and brain …

Mesenchymal stem cells (MSCs) have been shown to contribute to the recovery of tissues
through homing to injured areas, especially to hypoxic, apoptotic, or inflamed areas and …

Mesenchymal stem cells (MSCs) of bone marrow origin appear to be an attractive candidate
for cell-based therapies. However, the major barrier to the effective implementation of MSC …

Bone marrow-derived mesenchymal stem cells (MSCs) have the potential to differentiate
along different mesenchymal lineages including those forming bone, cartilage, tendon, fat …

Bone marrow-derived mesenchymal stem cells (MSCs) are multipotent and secrete
angiogenic factors, which could help patients with occlusive arterial diseases. We …